Brief: Orbimed Advisors Reports 16.7% Stake In Decibel Therapeutics As Of Feb 17
02/03/2021 11:12
March 2 (Reuters) - Decibel Therapeutics Inc DBTX.O :
* ORBIMED ADVISORS LLC REPORTS 16.7% STAKE IN DECIBEL
THERAPEUTICS
INC AS OF FEB 17 - SEC FILING
Source: https://bit.ly/2ObZTEu
Further company coverage: DBTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decibel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary